Carfilzomib alleviated osteoporosis by targeting PSME1/2 to activate Wnt/β-catenin signaling.
Zhang F, Attarilar S, Xie K, Han C, Qingyang Liang, Huang K, Lan C, Wang C, Yang C, Wang L, Mozafari M, Li K, Liu J, Tang Y.
Zhang F, et al. Among authors: attarilar s.
Mol Cell Endocrinol. 2022 Jan 15;540:111520. doi: 10.1016/j.mce.2021.111520. Epub 2021 Nov 24.
Mol Cell Endocrinol. 2022.
PMID: 34838695